Who
Daniel H. Petree
Director
Company insider
Files Form 4 as: Director, Sutro Biopharma; Director, Lpath; Director, Cypress Bioscience.
In numbers
- Trades disclosed
- 60
- Buys
- 1
- Sells
- 1
- Bought
- $28K
- Sold
- $1,830
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 2 Jan 2006
- Last trade
- 5 Jun 2026
- Last filed
- 9 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Jun 2026filed 9 Jun 2026 | STRO Sutro Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 5 Jun 2026filed 9 Jun 2026 | STRO Sutro Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 23 Dec 2025filed 29 Dec 2025 | STRO Sutro Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,500 at $0.00 | filing |
| 6 Jun 2025filed 10 Jun 2025 | STRO Sutro Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 6 Jun 2024filed 10 Jun 2024 | STRO Sutro Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
| 27 Jun 2023filed 29 Jun 2023 | STRO Sutro BiopharmaBiotechnology | SEC FORM 4 Code G | —18,409 at $0.00 | filing |
| 27 Jun 2023filed 29 Jun 2023 | STRO Sutro BiopharmaBiotechnology | SEC FORM 4 Code G | —18,409 at $0.00 | filing |
| 8 Jun 2023filed 12 Jun 2023 | STRO Sutro Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 6 Jun 2022filed 8 Jun 2022 | STRO Sutro Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —18,500 at $0.00 | filing |
| 8 Feb 2022filed 9 Feb 2022 | STRO Sutro Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code M | —4,545 at $0.00 | filing |
| 8 Feb 2022filed 9 Feb 2022 | STRO Sutro Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,617 at $0.00 | filing |
| 8 Feb 2022filed 9 Feb 2022 | STRO Sutro Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code M | —578 at $0.00 | filing |
| 8 Feb 2022filed 9 Feb 2022 | STRO Sutro Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code M | —873 at $0.00 | filing |
| 8 Feb 2022filed 9 Feb 2022 | STRO Sutro Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,124 at $0.00 | filing |
| 8 Feb 2022filed 9 Feb 2022 | STRO Sutro Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,540 at $0.00 | filing |
| 8 Feb 2022filed 9 Feb 2022 | STRO Sutro BiopharmaBiotechnology | SEC FORM 4 Code M | $20K4,545 at $4.36 | filing |
| 8 Feb 2022filed 9 Feb 2022 | STRO Sutro BiopharmaBiotechnology | SEC FORM 4 Code M | $11K2,617 at $4.36 | filing |
| 8 Feb 2022filed 9 Feb 2022 | STRO Sutro BiopharmaBiotechnology | SEC FORM 4 Code M | $3,358578 at $5.81 | filing |
| 8 Feb 2022filed 9 Feb 2022 | STRO Sutro BiopharmaBiotechnology | SEC FORM 4 Code M | $5,072873 at $5.81 | filing |
| 8 Feb 2022filed 9 Feb 2022 | STRO Sutro BiopharmaBiotechnology | SEC FORM 4 Code M | $12K2,124 at $5.81 | filing |
News
Tenaya Therapeutics (NASDAQ:TNYA) versus Sutro Biopharma (NASDAQ:STRO) Head-To-Head ComparisonSTRO · themarketsdaily.com · 20 Oct 2026
0 headlines in the last 90 days name Daniel H. Petree; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.